Tempus Acquires Deep 6 AI
March 11, 2025
Tempus AI, Inc. (NASDAQ: TEM) has acquired Deep 6 AI, an AI-powered precision research platform that matches patients to clinical trials by mining structured and unstructured EMR data. The acquisition expands Tempus' provider network (Deep 6 is integrated with 750+ provider sites covering more than 30 million patients) and enhances Tempus' clinical-trial matching and real-world evidence capabilities to accelerate recruitment and RWE generation.
- Buyers
- Tempus AI, Inc.
- Targets
- Deep 6 AI
- Industry
- Healthcare Services
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Tempus Acquires Highline Sciences
February 8, 2022
Healthcare Services
Tempus, the Chicago-based AI-driven precision medicine company, has acquired Highline Sciences, a San Francisco-based full-service clinical CRO focused on oncology. The acquisition will allow Tempus to vertically integrate additional clinical trial services and expand its capabilities to support and grow clinical research offerings for oncology therapeutics.
-
Tempus AI Acquires Paige for $81.25 Million
August 25, 2025
Healthcare Services
Tempus AI, Inc. (NASDAQ: TEM) is acquiring digital pathology company Paige for $81.25 million, primarily paid in Tempus common stock, and will assume Paige's remaining Microsoft Azure commitments. The deal expands Tempus's pathology dataset, technical team, and generative AI capabilities to accelerate development of large oncology foundation models and strengthen its precision medicine platform.
-
Rapid Care Acquires DeepDoc
January 23, 2026
Healthcare Services
Rapid Care has acquired DeepDoc, an AI platform that analyzes and summarizes unstructured medical records, to deepen its medical record intelligence capabilities and accelerate its AI roadmap. The deal expands Rapid Care’s suite of AI-enabled products used across insurance, medicolegal and provider workflows to streamline patient-to-payment operations and improve clinical and administrative decision support.
-
RadNet Acquires DeepHealth to Expand AI Capabilities
March 11, 2020
AI & Machine Learning
RadNet, Inc. has executed a definitive agreement to acquire DeepHealth, Inc., a Cambridge-based radiology AI and machine learning company focused on mammography and 3D breast imaging. The deal is structured as an initial share payment with up to additional milestone-based stock payments and aims to integrate DeepHealth's team and technology into RadNet's AI strategy to improve imaging interpretation and workflow efficiency.
-
Hippocratic AI Acquires Grove AI
January 12, 2026
AI & Machine Learning
Hippocratic AI has acquired Grove AI to accelerate its Life Sciences Division, integrating Grove AI's agentic AI platform and team to expand clinical engagement and trial operations capabilities. The move complements Hippocratic AI's Polaris safety architecture and follows its recent $126M Series C, while the company also launched a Life Sciences Executive Advisory Council and a strategic collaboration with BCG.
-
ZS Acquires Trials.ai to Add AI-Driven Study Design
February 6, 2023
AI & Machine Learning
Global consulting and technology firm ZS has entered into a definitive agreement to acquire Trials.ai, an AI-powered clinical study design company. The acquisition will integrate Trials.ai's intelligent study-design capabilities into ZS's clinical development offerings to help sponsors identify risks, optimize participant experience and accelerate therapy development timelines.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.